Medicated Skin Care in Hungary
Euromonitor International's Medicated Skin Care in Hungary market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 38 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN HUNGARY : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - HUNGARY
EGIS RT - OTC HEALTHCARE - HUNGARY
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Egis Rt: Key Facts
Summary 2 Egis Rt : Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Egis Rt: Competitive Position 2008
EXTRACTUM-PHARMA RT - OTC HEALTHCARE - HUNGARY
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Extractum-Pharma Rt: Key Facts
Summary 5 Extractum-Pharma Rt: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Extractum-Pharma Rt: Competitive Position 2008
PANNONPHARMA KFT - OTC HEALTHCARE - HUNGARY
STRATEGIC DIRECTION
KEY FACTS
Summary 7 PannonPharma Kft: Key Facts
Summary 8 PannonPharma Kft: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 PannonPharma Kft: Competitive Position 2008
RICHTER GEDEON RT - OTC HEALTHCARE - HUNGARY
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Richter Gedeon Rt: Key Facts
Summary 11 Richter Gedeon Rt: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Richter Gedeon Rt: Competitive Position 2008
TEVA MAGYARORSZáG RT - OTC HEALTHCARE - HUNGARY
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Teva Magyarország Rt: Key Facts
Summary 14 Teva Magyarország Rt: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Teva Magyarország Rt: Competitive Position 2008
OTC HEALTHCARE IN HUNGARY
EXECUTIVE SUMMARY
Trend towards self-medication drives modest market development in 2008
Chemists/pharmacies continue to dominate OTC healthcare distribution
Competitive landscape in analgesics shifts following 2007 switches
Deregulation leads to more intense competition in chemists/pharmacies
Self-medication trend will continue to benefit OTC healthcare over 2008-2013
KEY TRENDS AND DEVELOPMENTS
Economic and political problems inhibit OTC healthcare performance
OTC healthcare distribution outside chemists/pharmacies is slow to take off
Algoflex attempts to fill the space vacated by Algopyrin in analgesics
Pharmacy deregulation improves OTC healthcare distribution
Hungarians continue to live unhealthy lifestyles
MARKET INDICATORS
Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value 2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Penetration of Private Label by Sector 2003-2008
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Advertising
Packaging
Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 16 OTC Healthcare Switches: 2005-2007 (note: re-switch: the status of drugs was changed formerly from Rx to OTC, and current re-switch changed
DEFINITIONS
Summary 17 Research Sources